Pulmatrix, Inc.
General ticker "PULM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $22.9M (TTM average)
Pulmatrix, Inc. does not follow the US Stock Market performance with the rate: -20.6%.
Estimated limits based on current volatility of 2.4%: low 4.30$, high 4.51$
Factors to consider:
- Total employees count: 22 (-24.1%) as of 2023
- Top business risk factors: Net losses, Capital raising, Economic downturns and volatility, Labor/talent shortage/retention, Product candidate success
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.52$, 8.39$]
- 2025-12-31 to 2026-12-31 estimated range: [1.34$, 4.62$]
Financial Metrics affecting the PULM estimates:
- Negative: with PPE of -3.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -46.82 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 89.98 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
- Positive: -4.48 < Investing cash flow per share per price, % of -1.74
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term PULM quotes
Long-term PULM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $6.07MM | $7.30MM | $5.19MM |
| Operating Expenses | $25.02MM | $22.04MM | $14.95MM |
| Operating Income | $-18.95MM | $-14.74MM | $-9.76MM |
| Non-Operating Income | $0.11MM | $0.62MM | $0.20MM |
| R&D Expense | $18.24MM | $15.52MM | $7.17MM |
| Income(Loss) | $-18.84MM | $-14.12MM | $-9.56MM |
| Profit(Loss)* | $-18.84MM | $-14.12MM | $-9.56MM |
| Stockholders Equity | $31.11MM | $18.00MM | $8.95MM |
| Inventory | $0.15MM | $0.00MM | $0.00MM |
| Assets | $40.95MM | $33.96MM | $9.94MM |
| Operating Cash Flow | $-19.36MM | $-15.98MM | $-10.72MM |
| Capital expenditure | $0.09MM | $0.68MM | $0.40MM |
| Investing Cash Flow | $-0.09MM | $-0.68MM | $-0.40MM |
| Financing Cash Flow | $1.23MM | $0.05MM | $0.00MM |
| Earnings Per Share** | $-5.46 | $-3.87 | $-2.62 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.